Trends in Antibiotic Resistance in ICU Pathogens
Author Information
Author(s): Eagye Kathryn J, Nicolau David P, Lockhart Shawn R, Quinn John P, Doern Gary V, Gallagher Gale, Abramson Murray A
Primary Institution: Center for Anti-Infective Research and Development, Hartford Hospital
Hypothesis
Have MICs among major pathogens in the ICU increased enough to significantly impact their ability to achieve bactericidal effect?
Conclusion
Increasing antimicrobial resistance among ICU pathogens in the US has led to a decline in drug effectiveness, particularly for P. aeruginosa and Acinetobacter spp.
Supporting Evidence
- Imipenem showed a trend toward slightly improved bactericidal target attainment.
- Cefepime and piperacillin-tazobactam showed declines in effectiveness over time.
- Ceftriaxone had low predicted response rates across all periods.
Takeaway
Doctors need to give higher doses of certain antibiotics to help them work better against germs that are becoming stronger and harder to kill.
Methodology
Monte Carlo simulations were used to estimate the probability of achieving bactericidal effects of four antibiotics against Gram-negative bacilli from ICU patients.
Limitations
The study only included data from ICU patients in the US and may not be generalizable to other settings.
Participant Demographics
Patients with various infections in intensive care units in the United States.
Statistical Information
P-Value
<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website